GB202008651D0 - Method of identifying complement modulators - Google Patents

Method of identifying complement modulators

Info

Publication number
GB202008651D0
GB202008651D0 GBGB2008651.8A GB202008651A GB202008651D0 GB 202008651 D0 GB202008651 D0 GB 202008651D0 GB 202008651 A GB202008651 A GB 202008651A GB 202008651 D0 GB202008651 D0 GB 202008651D0
Authority
GB
United Kingdom
Prior art keywords
complement modulators
identifying
identifying complement
modulators
complement
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2008651.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Newcastle, The
Newcastle University of Upon Tyne
Original Assignee
University of Newcastle, The
Newcastle University of Upon Tyne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Newcastle, The, Newcastle University of Upon Tyne filed Critical University of Newcastle, The
Priority to GBGB2008651.8A priority Critical patent/GB202008651D0/en
Publication of GB202008651D0 publication Critical patent/GB202008651D0/en
Priority to PCT/GB2021/051359 priority patent/WO2021250375A1/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4716—Complement proteins, e.g. anaphylatoxin, C3a, C5a
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GBGB2008651.8A 2020-06-09 2020-06-09 Method of identifying complement modulators Ceased GB202008651D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2008651.8A GB202008651D0 (en) 2020-06-09 2020-06-09 Method of identifying complement modulators
PCT/GB2021/051359 WO2021250375A1 (en) 2020-06-09 2021-06-02 Method of identifying complement modulators

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2008651.8A GB202008651D0 (en) 2020-06-09 2020-06-09 Method of identifying complement modulators

Publications (1)

Publication Number Publication Date
GB202008651D0 true GB202008651D0 (en) 2020-07-22

Family

ID=71616002

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2008651.8A Ceased GB202008651D0 (en) 2020-06-09 2020-06-09 Method of identifying complement modulators

Country Status (2)

Country Link
GB (1) GB202008651D0 (en)
WO (1) WO2021250375A1 (en)

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
DE3920358A1 (en) 1989-06-22 1991-01-17 Behringwerke Ag BISPECIFIC AND OLIGO-SPECIFIC, MONO- AND OLIGOVALENT ANTI-BODY CONSTRUCTS, THEIR PRODUCTION AND USE
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US5625126A (en) 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
ES2246502T3 (en) 1990-08-29 2006-02-16 Genpharm International, Inc. TRANSGENIC NON-HUMAN ANIMALS ABLE TO PRODUCE HETEROLOGICAL ANTIBODIES.
DE69129154T2 (en) 1990-12-03 1998-08-20 Genentech, Inc., South San Francisco, Calif. METHOD FOR ENRICHING PROTEIN VARIANTS WITH CHANGED BINDING PROPERTIES
CA2122732C (en) 1991-11-25 2008-04-08 Marc D. Whitlow Multivalent antigen-binding proteins
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
US5739277A (en) 1995-04-14 1998-04-14 Genentech Inc. Altered polypeptides with increased half-life
GB201301632D0 (en) * 2013-01-30 2013-03-13 Imp Innovations Complement System

Also Published As

Publication number Publication date
WO2021250375A1 (en) 2021-12-16

Similar Documents

Publication Publication Date Title
EP3859571A4 (en) Method and apparatus for allocating copyrights of works based on blockchain
EP3317985A4 (en) Transmission apparatus and transmission method of resource assignment information
EP3887481A4 (en) A method of treating refractory epilepsy syndromes using fenfluramine enantiomers
ZA202004497B (en) Process of making somatostatin modulators
IL289861A (en) Modulators of trex1
GB2580264B (en) Optical modulator and method of fabricating an optical modulator
EP3699840A4 (en) Method for analyzing supply chain risk of suppliers
GB2576553B (en) Method of hologram calculation
EP3948721A4 (en) System and method of identifying equivalents for task completion
EP4068878A4 (en) Method and apparatus for indicating number of repeated transmissions
EP3836317A4 (en) Method and corresponding apparatus for reducing backlight crosstalk impact of optical assembly
IL256690B (en) System and method for identifying pairs of related application users
GB202018412D0 (en) Malt-1 modulators ii
GB202008651D0 (en) Method of identifying complement modulators
IL308016A (en) Modulators of trex1
IL287684A (en) Modulators of trex1
IL285333A (en) Modulators of malat1 expression
IL287250A (en) Method of treatment
KR102295306B9 (en) Class-movable bridge apparatus
SG10202007447RA (en) Removal method of carrier plate
GB2604979B (en) Optical modulator and method of fabricating an optical modulator
SG10202007436PA (en) Method of removing carrier plate
IL308220A (en) Modulators of trex1
GB202109732D0 (en) Method of resource assessment
EP4072724C0 (en) Method of removing mercury

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)